 | • レポートコード：GIR201115642 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、免疫細胞療法の世界市場を調査対象にし、免疫細胞療法の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（キメラ抗原受容体（CAR）T細胞療法、ナチュラルキラー（NK）細胞療法、その他）、用途別分析（病院、診療所、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Gilead Sciences、Novartis ・企業別売上、市場シェア ・免疫細胞療法の地域別市場分析 ・免疫細胞療法の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・免疫細胞療法のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・免疫細胞療法のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・免疫細胞療法の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・免疫細胞療法の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・免疫細胞療法の種類別市場規模2015-2020：キメラ抗原受容体（CAR）T細胞療法、ナチュラルキラー（NK）細胞療法、その他 ・免疫細胞療法の用途別市場規模2015-2020：病院、診療所、その他 ・免疫細胞療法の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The Immunocell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Immunocell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Immunocell Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Immunocell Therapy market has been segmented into:
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Others
By Application, Immunocell Therapy has been segmented into:
Hospitals
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Immunocell Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Immunocell Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Immunocell Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Immunocell Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Immunocell Therapy Market Share Analysis
Immunocell Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Immunocell Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Immunocell Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Immunocell Therapy are:
Gilead Sciences
Novartis
Among other players domestic and global, Immunocell Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Immunocell Therapy Market Overview
1.1 Product Overview and Scope of Immunocell Therapy
1.2 Classification of Immunocell Therapy by Type
1.2.1 Global Immunocell Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Immunocell Therapy Revenue Market Share by Type in 2019
1.2.3 Chimeric Antigen Receptor (CAR) T Cell Therapy
1.2.4 Natural Killer (NK) Cell Therapy
1.2.5 Others
1.3 Global Immunocell Therapy Market by Application
1.3.1 Overview: Global Immunocell Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Immunocell Therapy Market by Regions
1.4.1 Global Immunocell Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Immunocell Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Immunocell Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Immunocell Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immunocell Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Immunocell Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immunocell Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences SWOT Analysis
2.1.4 Gilead Sciences Product and Services
2.1.5 Gilead Sciences Immunocell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Immunocell Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Immunocell Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Immunocell Therapy Players Market Share
3.2.2 Top 10 Immunocell Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Immunocell Therapy Revenue and Market Share by Regions
4.2 North America Immunocell Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Immunocell Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Immunocell Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Immunocell Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Immunocell Therapy Revenue and Growth Rate (2015-2020)
5 North America Immunocell Therapy Revenue by Countries
5.1 North America Immunocell Therapy Revenue by Countries (2015-2020)
5.2 USA Immunocell Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Immunocell Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Immunocell Therapy Revenue and Growth Rate (2015-2020)
6 Europe Immunocell Therapy Revenue by Countries
6.1 Europe Immunocell Therapy Revenue by Countries (2015-2020)
6.2 Germany Immunocell Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Immunocell Therapy Revenue and Growth Rate (2015-2020)
6.4 France Immunocell Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Immunocell Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Immunocell Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Immunocell Therapy Revenue by Countries
7.1 Asia-Pacific Immunocell Therapy Revenue by Countries (2015-2020)
7.2 China Immunocell Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Immunocell Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Immunocell Therapy Revenue and Growth Rate (2015-2020)
7.5 India Immunocell Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Immunocell Therapy Revenue and Growth Rate (2015-2020)
8 South America Immunocell Therapy Revenue by Countries
8.1 South America Immunocell Therapy Revenue by Countries (2015-2020)
8.2 Brazil Immunocell Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Immunocell Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Immunocell Therapy by Countries
9.1 Middle East & Africa Immunocell Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Immunocell Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Immunocell Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Immunocell Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Immunocell Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Immunocell Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Immunocell Therapy Market Forecast by Type (2019-2024)
10.3 Chimeric Antigen Receptor (CAR) T Cell Therapy Revenue Growth Rate (2015-2025)
10.4 Natural Killer (NK) Cell Therapy Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Immunocell Therapy Market Segment by Application
11.1 Global Immunocell Therapy Revenue Market Share by Application (2015-2020)
11.2 Immunocell Therapy Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Immunocell Therapy Market Size Forecast (2021-2025)
12.1 Global Immunocell Therapy Market Size Forecast (2021-2025)
12.2 Global Immunocell Therapy Market Forecast by Regions (2021-2025)
12.3 North America Immunocell Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Immunocell Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Immunocell Therapy Revenue Market Forecast (2021-2025)
12.6 South America Immunocell Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Immunocell Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Immunocell Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Immunocell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Immunocell Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Immunocell Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Immunocell Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Gilead Sciences Corporate Information, Location and Competitors
Table 7. Gilead Sciences Immunocell Therapy Major Business
Table 8. Gilead Sciences Immunocell Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Gilead Sciences SWOT Analysis
Table 10. Gilead Sciences Immunocell Therapy Product and Solutions
Table 11. Gilead Sciences Immunocell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Novartis Corporate Information, Location and Competitors
Table 13. Novartis Immunocell Therapy Major Business
Table 14. Novartis Immunocell Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Novartis SWOT Analysis
Table 16. Novartis Immunocell Therapy Product and Solutions
Table 17. Novartis Immunocell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Global Immunocell Therapy Revenue (Million USD) by Players (2015-2020)
Table 19. Global Immunocell Therapy Revenue Share by Players (2015-2020)
Table 20. Global Immunocell Therapy Revenue (Million USD) by Regions (2015-2020)
Table 21. Global Immunocell Therapy Revenue Market Share by Regions (2015-2020)
Table 22. North America Immunocell Therapy Revenue by Countries (2015-2020)
Table 23. North America Immunocell Therapy Revenue Market Share by Countries (2015-2020)
Table 24. Europe Immunocell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 25. Asia-Pacific Immunocell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 26. South America Immunocell Therapy Revenue by Countries (2015-2020)
Table 27. South America Immunocell Therapy Revenue Market Share by Countries (2015-2020)
Table 28. Middle East and Africa Immunocell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 29. Middle East and Africa Immunocell Therapy Revenue Market Share by Countries (2015-2020)
Table 30. Global Immunocell Therapy Revenue (Million USD) by Type (2015-2020)
Table 31. Global Immunocell Therapy Revenue Share by Type (2015-2020)
Table 32. Global Immunocell Therapy Revenue Forecast by Type (2021-2025)
Table 33. Global Immunocell Therapy Revenue by Application (2015-2020)
Table 34. Global Immunocell Therapy Revenue Share by Application (2015-2020)
Table 35. Global Immunocell Therapy Revenue Forecast by Application (2021-2025)
Table 36. Global Immunocell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Immunocell Therapy Picture
Figure 2. Global Immunocell Therapy Revenue Market Share by Type in 2019
Figure 3. Chimeric Antigen Receptor (CAR) T Cell Therapy Picture
Figure 4. Natural Killer (NK) Cell Therapy Picture
Figure 5. Others Picture
Figure 6. Immunocell Therapy Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Others Picture
Figure 10. Global Immunocell Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Immunocell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Immunocell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Immunocell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Immunocell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Immunocell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Immunocell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Immunocell Therapy Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Immunocell Therapy Revenue Market Share in 2019
Figure 19. Global Top 10 Players Immunocell Therapy Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Immunocell Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Immunocell Therapy Revenue Market Share by Regions (2015-2020)
Figure 23. Global Immunocell Therapy Revenue Market Share by Regions in 2018
Figure 24. North America Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 25. Europe Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 27. South America Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 29. North America Immunocell Therapy Revenue Market Share by Countries (2015-2020)
Figure 30. North America Immunocell Therapy Revenue Market Share by Countries in 2019
Figure 31. USA Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Canada Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Europe Immunocell Therapy Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Immunocell Therapy Revenue Market Share by Countries in 2019
Figure 36. Germany Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 37. UK Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 38. France Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Russia Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Italy Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Immunocell Therapy Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Immunocell Therapy Revenue Market Share by Countries in 2019
Figure 43. China Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 44. Japan Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Korea Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 46. India Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 48. South America Immunocell Therapy Revenue Market Share by Countries (2015-2020)
Figure 49. South America Immunocell Therapy Revenue Market Share by Countries in 2019
Figure 50. Brazil Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Immunocell Therapy Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Immunocell Therapy Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 55. UAE Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Immunocell Therapy Revenue and Growth Rate (2015-2020)
Figure 58. Global Immunocell Therapy Revenue Share by Type (2015-2020)
Figure 59. Global Immunocell Therapy Revenue Share by Type in 2019
Figure 60. Global Immunocell Therapy Market Share Forecast by Type (2021-2025)
Figure 61. Global Chimeric Antigen Receptor (CAR) T Cell Therapy Revenue Growth Rate (2015-2020)
Figure 62. Global Natural Killer (NK) Cell Therapy Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Immunocell Therapy Revenue Share by Application (2015-2020)
Figure 65. Global Immunocell Therapy Revenue Share by Application in 2019
Figure 66. Global Immunocell Therapy Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Immunocell Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Immunocell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Immunocell Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Immunocell Therapy Revenue Market Forecast (2021-2025)
Figure 74. Europe Immunocell Therapy Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Immunocell Therapy Revenue Market Forecast (2021-2025)
Figure 76. South America Immunocell Therapy Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Immunocell Therapy Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
筋骨格障害幹細胞療法の世界市場 2020年 Market Overview The global Musculoskeletal Disorder Stem Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mu…- 細胞療法の世界市場 2020年 Market Overview The Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 幹細胞治療の世界市場 2020年 Market Overview The Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 細胞移植療法の世界市場 2020年 Market Overview The Cell Transplantatio Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 動物幹細胞療法の世界市場 2020年 Market Overview The Animal Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…